GMP Raw Materials & Ancillary Materials Vendors

Compare suppliers of GMP-grade raw materials and ancillary materials for biopharmaceutical manufacturing, cell processing and therapy production.

Related workflows

Favicon of VectorBuilder

CDMO / CMO · +4 more types

VectorBuilder provides CRO and CDMO services for gene therapy vectors, plasmids, RNA therapeutics, discovery programs, and related testing.

Products: LentiBuilder, CliniVec +1 more

Evidence-backed capability match
Matches GMP Raw Materials & Ancillary Materials
“VectorBuilder offers GMP-like and GMP-grade lentivirus and AAV packaging plasmids for the manufacturing of pre-clinical and clinical viral vectors for gene and cell therapies…”
Source: en.vectorbuilder.com

Also offers: AAV & Lentiviral Vector Manufacturing, Plasmid DNA Manufacturing, +3 more

BioIVT supplies human and animal biospecimens, hepatocytes, PBMCs and other primary cells, plus ADME, DDI, bioanalysis and in vitro assay services.
Evidence-backed capability match
Matches GMP Raw Materials & Ancillary Materials
“BioIVT’s is available in research‑ and GMP‑grade formats, including plasma‑derived and off‑the‑clot options, designed to support scalable cell culture, cell therapy research, and…”
Source: bioivt.com

Also offers: Cell Culture, Cell Models & Organoid Products, Human Biospecimens & Biobank Samples, +2 more

Compare listed vendors

What this covers: GMP-grade raw and ancillary materials supplied for regulated biopharmaceutical manufacturing, cell processing, or therapeutic production.

VendorDelivery modelAlso offersIn their words
BioIVTProduct / Instrument Supplier—“BioIVT’s is available in research‑ and GMP‑grade formats, including plasma‑derived and off‑the‑clot options, designed to support scalable cell culture, cell…”bioivt.com · reviewed Oct 25, 2026
VectorBuilderCDMO / CMO—“VectorBuilder offers GMP-like and GMP-grade lentivirus and AAV packaging plasmids for the manufacturing of pre-clinical and clinical viral vectors for gene and…”en.vectorbuilder.com · reviewed Oct 14, 2026